1315 related articles for article (PubMed ID: 9755289)
1. Receptors for purines and pyrimidines.
Ralevic V; Burnstock G
Pharmacol Rev; 1998 Sep; 50(3):413-92. PubMed ID: 9755289
[No Abstract] [Full Text] [Related]
2. Purine and pyrimidine receptors.
Burnstock G
Cell Mol Life Sci; 2007 Jun; 64(12):1471-83. PubMed ID: 17375261
[TBL] [Abstract][Full Text] [Related]
3. Animal models for the study of adenosine receptor function.
Yaar R; Jones MR; Chen JF; Ravid K
J Cell Physiol; 2005 Jan; 202(1):9-20. PubMed ID: 15389588
[TBL] [Abstract][Full Text] [Related]
4. Presynaptic adenosine and P2Y receptors.
Gonçalves J; Queiroz G
Handb Exp Pharmacol; 2008; (184):339-72. PubMed ID: 18064419
[TBL] [Abstract][Full Text] [Related]
5. Purinergic receptors in gastrointestinal inflammation.
Kolachala VL; Bajaj R; Chalasani M; Sitaraman SV
Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G401-10. PubMed ID: 18063703
[TBL] [Abstract][Full Text] [Related]
6. Localization of adenosine receptor messenger RNAs in the rat eye.
Kvanta A; Seregard S; Sejersen S; Kull B; Fredholm BB
Exp Eye Res; 1997 Nov; 65(5):595-602. PubMed ID: 9367639
[TBL] [Abstract][Full Text] [Related]
7. Modulation of murine dendritic cell function by adenine nucleotides and adenosine: involvement of the A(2B) receptor.
Ben Addi A; Lefort A; Hua X; Libert F; Communi D; Ledent C; Macours P; Tilley SL; Boeynaems JM; Robaye B
Eur J Immunol; 2008 Jun; 38(6):1610-20. PubMed ID: 18465770
[TBL] [Abstract][Full Text] [Related]
8. Expression of adenosine receptors in the preglomerular microcirculation.
Jackson EK; Zhu C; Tofovic SP
Am J Physiol Renal Physiol; 2002 Jul; 283(1):F41-51. PubMed ID: 12060585
[TBL] [Abstract][Full Text] [Related]
9. Expression of both P1 and P2 purine receptor genes by human articular chondrocytes and profile of ligand-mediated prostaglandin E2 release.
Koolpe M; Pearson D; Benton HP
Arthritis Rheum; 1999 Feb; 42(2):258-67. PubMed ID: 10025919
[TBL] [Abstract][Full Text] [Related]
10. Differential gene expression of adenosine A1, A2a, A2b, and A3 receptors in the human enteric nervous system.
Christofi FL; Zhang H; Yu JG; Guzman J; Xue J; Kim M; Wang YZ; Cooke HJ
J Comp Neurol; 2001 Oct; 439(1):46-64. PubMed ID: 11579381
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of a second generation of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as potent and selective A2A adenosine receptor antagonists.
Baraldi PG; Cacciari B; Spalluto G; Bergonzoni M; Dionisotti S; Ongini E; Varani K; Borea PA
J Med Chem; 1998 Jun; 41(12):2126-33. PubMed ID: 9622554
[TBL] [Abstract][Full Text] [Related]
12. Mast cell-mediated stimulation of angiogenesis: cooperative interaction between A2B and A3 adenosine receptors.
Feoktistov I; Ryzhov S; Goldstein AE; Biaggioni I
Circ Res; 2003 Mar; 92(5):485-92. PubMed ID: 12600879
[TBL] [Abstract][Full Text] [Related]
13. New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2.
Baraldi PG; Romagnoli R; Tabrizi MA; Bovero A; Preti D; Fruttarolo F; Moorman AR; Borea PA
Farmaco; 2005 Mar; 60(3):185-202. PubMed ID: 15784237
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological evaluation of novel 1- and 8-substituted-3-furfuryl xanthines as adenosine receptor antagonists.
Balo MC; Brea J; Caamaño O; Fernández F; García-Mera X; López C; Loza MI; Nieto MI; Rodríguez-Borges JE
Bioorg Med Chem; 2009 Sep; 17(18):6755-60. PubMed ID: 19682912
[TBL] [Abstract][Full Text] [Related]
15. Membrane compartments and purinergic signalling.
Barth K; Volonté C
FEBS J; 2009 Jan; 276(2):317. PubMed ID: 19076213
[No Abstract] [Full Text] [Related]
16. Age-related changes in cardiac adenosine receptor expression.
Jenner TL; Mellick AS; Harrison GJ; Griffiths LR; Rose'Meyer RB
Mech Ageing Dev; 2004 Mar; 125(3):211-7. PubMed ID: 15013665
[TBL] [Abstract][Full Text] [Related]
17. Cloning of two adenosine receptor subtypes from mouse bone marrow-derived mast cells.
Marquardt DL; Walker LL; Heinemann S
J Immunol; 1994 May; 152(9):4508-15. PubMed ID: 8157966
[TBL] [Abstract][Full Text] [Related]
18. The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist.
Zocchi C; Ongini E; Conti A; Monopoli A; Negretti A; Baraldi PG; Dionisotti S
J Pharmacol Exp Ther; 1996 Feb; 276(2):398-404. PubMed ID: 8632302
[TBL] [Abstract][Full Text] [Related]
19. Modulation of innate immunity by adenosine receptor stimulation.
Ramakers BP; Riksen NP; van der Hoeven JG; Smits P; Pickkers P
Shock; 2011 Sep; 36(3):208-15. PubMed ID: 21617576
[TBL] [Abstract][Full Text] [Related]
20. Involvement of purinergic signaling in cardiovascular diseases.
Ralevic V; Burnstock G
Drug News Perspect; 2003 Apr; 16(3):133-40. PubMed ID: 12819811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
